We are live on
!
Find out more
Man Group Portfolio holdings
AUM
$62.7B
Turnover
25.36%
1-Year Est. Return
29.77%
This Fund
S&P 500
This Quarter
Est. Return
-1.99%
1 Year Est. Return
+29.77%
3 Year Est. Return
+99.46%
5 Year Est. Return
+125.78%
10 Year Est. Return
–
AUM
$55.1B
AUM Growth
-$3.71B
(-6.3%)
Cap. Flow
-$2.01B
Cap. Flow
% of AUM
-3.65%
Top 10 Holdings %
Top 10 Hldgs %
15.88%
Holding
2,628
New
414
Increased
1,064
Reduced
775
Closed
261
Avg Time Held Equity + Options
1.2
years
Top 10 Avg Time Held Equity + Options
1.5
years
Top 20 Avg Time Held Equity + Options
1
year
Avg Time Held Equity only
1.2
years
Top 10 Avg Time Held Equity only
1.5
years
Top 20 Avg Time Held Equity only
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HDFC Bank
HDB
|
+$185M |
| 2 |
PepsiCo
PEP
|
+$176M |
| 3 |
TE Connectivity
TEL
|
+$166M |
| 4 |
Ford
F
|
+$131M |
| 5 |
3M
MMM
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$418M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$352M |
| 3 |
Amazon
AMZN
|
+$296M |
| 4 |
NVIDIA
NVDA
|
+$237M |
| 5 |
Eaton
ETN
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.85% |
| 2 | Miscellaneous | 14.37% |
| 3 | Financials | 10.33% |
| 4 | Healthcare | 9.99% |
| 5 | Consumer Discretionary | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2001
PUT
Texas Instruments
TXN
$253B
| $485K | ﹤0.01% |
2,500
-27,000
| -92% | -$5.47M |
2025 Q3
2 quarters
|
|
2002
Spyre Therapeutics
SYRE
$7.32B
| $482K | ﹤0.01% |
+9,546
| New | +$360K |
2026 Q1
0 quarters
|
|
2003
Oil States International
OIS
$480M
| $481K | ﹤0.01% |
41,311
-24,814
| -38% | -$256K |
2025 Q3
2 quarters
|
|
2004
ArriVent BioPharma
AVBP
$812M
| $478K | ﹤0.01% |
+20,727
| New | +$468K |
2026 Q1
0 quarters
|
|
2005
Ardelyx
ARDX
$849M
| $477K | ﹤0.01% |
79,602
-44,609
| -36% | -$295K |
2025 Q1
4 quarters
|
|
2006
STAAR Surgical
STAA
$1.12B
| $474K | ﹤0.01% |
+25,356
| New | +$484K |
2026 Q1
0 quarters
|
|
2007
Mako Mining
MAKO
$770M
| $474K | ﹤0.01% |
+73,800
| New | +$457K |
2026 Q1
0 quarters
|
|
2008
Core Natural Resources Inc
CNR
$4.37B
| $473K | ﹤0.01% |
+4,515
| New | +$430K |
2026 Q1
0 quarters
|
|
2009
Central Pacific Financial
CPF
$927M
| $472K | ﹤0.01% |
+14,764
| New | +$476K |
2026 Q1
0 quarters
|
|
2010
Urban Outfitters
URBN
$7.53B
| $470K | ﹤0.01% |
7,424
-242,100
| -97% | -$16.6M |
2025 Q3
2 quarters
|
|
2011
LCI Industries
LCII
$2.02B
| $468K | ﹤0.01% |
3,807
+547
| +17% | +$74.8K |
2024 Q2
7 quarters
|
|
2012
CALL
State Street Utilities Select Sector SPDR ETF
XLU
$24.1B
| $468K | ﹤0.01% |
10,200
-57,500
| -85% | -$2.58M |
2024 Q2
7 quarters
|
|
2013
Levi Strauss
LEVI
$7.87B
| $467K | ﹤0.01% |
25,266
-437,465
| -95% | -$8.96M |
2023 Q4
9 quarters
|
|
2014
RF Industries
RFIL
$78.3M
| $467K | ﹤0.01% |
45,305
+18,682
| +70% | +$189K |
2025 Q4
1 quarter
|
|
2015
CALL
Estee Lauder
EL
$38.7B
| $467K | ﹤0.01% |
6,500
+1,500
| +30% | +$153K |
2025 Q3
2 quarters
|
|
|
2016
PUT
Estee Lauder
EL
$38.7B
| $467K | ﹤0.01% |
6,500
+1,500
| +30% | +$153K |
2025 Q3
2 quarters
|
|
2017
FreightCar America
RAIL
$201M
| $465K | ﹤0.01% |
58,385
+27,642
| +90% | +$313K |
2024 Q4
5 quarters
|
|
2018
Wave Life Sciences
WVE
$617M
| $464K | ﹤0.01% |
64,036
+32,618
| +104% | +$425K |
2025 Q2
3 quarters
|
|
2019
Kyverna Therapeutics
KYTX
$364M
| $462K | ﹤0.01% |
+53,543
| New | +$446K |
2026 Q1
0 quarters
|
|
2020
EverQuote
EVER
$753M
| $461K | ﹤0.01% |
29,917
-11,671
| -28% | -$221K |
2025 Q2
3 quarters
|
|
2021
La-Z-Boy
LZB
$1.22B
| $460K | ﹤0.01% |
+14,309
| New | +$517K |
2026 Q1
0 quarters
|
|
2022
Transcat
TRNS
$766M
| $458K | ﹤0.01% |
6,230
-6,050
| -49% | -$426K |
2025 Q4
1 quarter
|
|
2023
Kamada
KMDA
$450M
| $457K | ﹤0.01% |
54,758
+20,464
| +60% | +$172K |
2025 Q3
2 quarters
|
|
2024
UroGen Pharma
URGN
$1.78B
| $457K | ﹤0.01% |
+25,395
| New | +$509K |
2026 Q1
0 quarters
|
|
2025
NETSTREIT Corp
NTST
$1.75B
| $456K | ﹤0.01% |
+24,199
| New | +$466K |
2026 Q1
0 quarters
|
|
Similar funds
Man Group's Q1 2026 Portfolio in Review
As of Q1 2026, Man Group held 2,628 positions worth $55.1B, down 6.3% from $58.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Man Group withdrew a net $2.01B in Q1 2026, closing 261 positions and reducing 775 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $418M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Miscellaneous and Financials.
Against the trend, Man Group opened a new position in AstraZeneca worth $122M.
- Man Group's largest Q1 2026 buy was AstraZeneca: 628,476 shares worth $122M.
- Man Group added most to HDFC Bank in Q1 2026, an estimated $185M increase.
- Man Group's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $352M.
- Man Group fully exited State Street SPDR S&P 500 ETF Trust in Q1 2026, selling an estimated $418M.
- Man Group's ten largest holdings make up 16% of its $55.1B portfolio in Q1 2026.
- Man Group opened 414 new positions and closed 261 in Q1 2026.
- Man Group's portfolio value fell 6.3% quarter-over-quarter to $55.1B.
Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.